GO:0070235 regulation of activation-induced cell death of T cells: Apoptosis Control, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0070235 describes any process that modulates the occurrence or rate of activation-induced cell death (AICD) of T cells.
• AICD is a form of antigen-driven apoptosis that eliminates repeatedly activated mature T lymphocytes and helps terminate immune responses.
• Fas/FasL signaling is a central execution pathway, and regulation of FasL expression is a key control point in AICD.
• AICD is important for peripheral tolerance, immune homeostasis, and prevention of autoimmunity.
• Tumor and hypoxic microenvironments can alter AICD sensitivity, affecting tumor immunoescape and T cell persistence.
• CRISPR knockout, knock-in, point-mutation, and overexpression models enable causal dissection of AICD regulators.
Description
Regulation of activation-induced cell death of T cells (GO:0070235) is a biological process that controls the occurrence or rate of activation-induced cell death (AICD) in T lymphocytes. AICD is a programmed cell death triggered by repeated T cell receptor stimulation and is essential for shutting down immune responses after antigen clearance. Because AICD removes activated T cells, its dysregulation can lead to persistent inflammation, autoimmunity, or impaired tumor immunity. Understanding how AICD is regulated therefore has broad implications for immunology, cancer biology, and immunotherapy. This article integrates the QuickGO definition with verified PubMed literature to summarize the mechanisms, key genes, disease links, and experimental models relevant to GO:0070235.
regulation of activation-induced cell death of T cells At A Glance
| GO ID | GO:0070235 |
|---|---|
| GO term | regulation of activation-induced cell death of T cells |
| Ontology | biological_process |
| Synonym | regulation of AICD; regulation of activated T cell apoptosis; regulation of antigen-driven apoptosis |
| Major function | Modulates the occurrence or rate of activation-induced cell death of T cells |
| Biological context | Peripheral tolerance, immune response termination, T cell homeostasis |
| Key pathways | Fas/FasL, TCR signaling, cytokine and metabolic signals |
| Disease relevance | Autoimmunity, cancer immunoescape, chronic infection, type 2 diabetes |
What Is GO:0070235?
GO:0070235 is defined by QuickGO as any process that modulates the occurrence or rate of activation-induced cell death of T cells. In other words, it is the regulatory layer that determines whether, when, and how quickly activated T cells undergo apoptosis following antigen-driven activation. This includes positive and negative regulation of AICD, control of death receptor expression, and integration of survival and death signals.
Why Is regulation of activation-induced cell death of T cells Important in Cell Biology?
Regulation of AICD is critical because it determines the size and persistence of T cell responses. Proper AICD prevents excessive T cell expansion and autoimmunity, while defective AICD can sustain harmful inflammation or allow tumor-specific T cells to be eliminated in the tumor microenvironment. Thus, GO:0070235 sits at the intersection of immune homeostasis, tolerance, and cancer immunotherapy.
• Controls termination of immune responses after antigen clearance.
• Maintains peripheral tolerance and prevents autoimmunity.
• Regulates T cell homeostasis and repertoire contraction.
• Modulates tumor immunoescape by sensitizing tumor-specific T cells to AICD.
• Is influenced by hypoxia and glycolysis in the tumor microenvironment.
• Contributes to immunopathology in type 2 diabetes via OX40 amplification.
• Provides targets for modulating T cell persistence in immunotherapy.
• Helps explain differential sensitivity of T cell subsets to apoptosis.
What Happens During regulation of activation-induced cell death of T cells?
T cell activation and repeated TCR stimulation
In simple terms: T cells receive strong or repeated signals through their antigen receptor, which sets the stage for a self-destruct program.
AICD is initiated when mature T lymphocytes are repeatedly stimulated through the T cell receptor (TCR). This repeated activation induces a death program that is distinct from passive cell death and depends on new gene expression and signaling events. The regulation of AICD therefore begins with the strength, duration, and context of TCR engagement.
FasL induction and death receptor signaling
In simple terms: Activated T cells start producing a death ligand called FasL, which can trigger their own or neighboring T cells to die.
A central mechanism of AICD is the induction of Fas ligand (FasL) and its interaction with Fas (CD95) on T cells. Regulation of FasL expression is a key control point, and multiple transcription factors and signaling pathways modulate its levels. This death receptor pathway leads to caspase activation and apoptosis of activated T cells.
Integration of survival and death signals
In simple terms: The cell weighs pro-survival and pro-death signals to decide whether to live or die.
AICD is regulated by a balance between pro-apoptotic and pro-survival signals. Cytokines, costimulatory molecules, and metabolic cues can either sensitize or protect T cells from AICD. For example, OX40 signaling amplifies AICD in mucosal-associated invariant T cells from type 2 diabetic patients. This integration ensures that AICD occurs only under appropriate conditions.
Metabolic and microenvironmental control
In simple terms: The environment around the T cell, such as oxygen and nutrient levels, can change how easily it dies.
Hypoxia and metabolic reprogramming influence AICD. HIF1α-regulated glycolysis promotes AICD and IFN-γ induction in hypoxic T cells. In tumors, mutant KRAS-activated circATXN7 sensitizes tumor-specific T cells to AICD, contributing to immunoescape. Thus, regulation of AICD is tightly linked to the tissue microenvironment.
Execution of apoptosis and immune response termination
In simple terms: Once the decision is made, the T cell dismantles itself, which helps end the immune response.
Following the regulatory decision, AICD proceeds through caspase-dependent apoptosis, leading to clearance of activated T cells. This contraction phase is essential for restoring immune homeostasis and preventing chronic inflammation. Defects in this regulation can result in accumulation of autoreactive T cells.
Key Genes Involved in GO:0070235 regulation of activation-induced cell death of T cells
The following genes and proteins are central to the regulation of activation-induced cell death of T cells, based on verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| FASLG (FasL) | Death ligand that triggers Fas-mediated apoptosis | Key target for modulating AICD |
| FAS (CD95) | Death receptor for FasL | Central to AICD execution |
| TNFRSF4 (OX40) | Costimulatory receptor that amplifies AICD | Linked to type 2 diabetes AICD enhancement |
| HIF1A | Hypoxia-inducible factor regulating glycolysis | Promotes AICD in hypoxic T cells |
| KRAS | Oncogene; mutant KRAS alters tumor microenvironment | Indirectly sensitizes T cells to AICD via circATXN7 |
| CASP3 | Executioner caspase in apoptosis | Downstream of AICD pathways |
| CASP8 | Initiator caspase in death receptor signaling | Mediates Fas-induced AICD |
| BCL2 | Anti-apoptotic protein | Modulates susceptibility to AICD |
| BCL2L1 (Bcl-xL) | Anti-apoptotic protein | Influences T cell survival during AICD |
| NFKB1 | Transcription factor regulating FasL expression | Controls AICD sensitivity |
| NFATC1 | Transcription factor downstream of TCR | Regulates FasL induction |
| IL2 | Cytokine promoting T cell survival/proliferation | Can prime or protect from AICD |
| IL2RA (CD25) | High-affinity IL-2 receptor subunit | Modulates AICD in activated T cells |
| CTLA4 | Inhibitory receptor | Regulates T cell activation and AICD |
| PDCD1 (PD-1) | Inhibitory receptor | Influences T cell survival and AICD |
| STAT5A | Transcription factor downstream of cytokines | Promotes survival signals opposing AICD |
| FOXP3 | Regulatory T cell transcription factor | Regulates T cell subset sensitivity to AICD |
| ATG5 | Autophagy-related protein | May modulate AICD through autophagy |
How Is regulation of activation-induced cell death of T cells Regulated?
Regulation of AICD is controlled by multiple layers, including TCR signal strength, costimulation, cytokines, and metabolic pathways. The IL-2/STAT5 axis can promote survival and oppose AICD, while FasL induction and death receptor signaling promote it. Hypoxia and HIF1α-driven glycolysis enhance AICD in specific contexts. Tumor-derived factors such as mutant KRAS-activated circATXN7 can sensitize T cells to AICD, illustrating microenvironmental regulation. OX40 costimulation amplifies AICD in certain disease settings.
regulation of activation-induced cell death of T cells and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| FASLG | Autoimmunity, cancer immunoescape | Faslg knockout or knock-in reporter T cells |
| HIF1A | Hypoxic tumor microenvironment | Hif1a conditional knockout T cells |
| KRAS | Tumor immunoescape | Mutant KRAS tumor models with T cell co-culture |
| TNFRSF4 (OX40) | Type 2 diabetes, chronic inflammation | OX40 agonist/antagonist in T cell cultures |
| FOXP3 | Autoimmunity, tolerance | Foxp3 knockout or reporter mice |
Autoimmunity and peripheral tolerance
Defective regulation of AICD can lead to failure of peripheral tolerance, allowing autoreactive T cells to persist and cause autoimmune disease. Proper AICD is required to delete activated autoreactive T cells after an immune response. Therefore, genes controlling AICD are candidate modifiers of autoimmune susceptibility.
Cancer immunoescape
Tumor cells can create microenvironments that sensitize tumor-specific T cells to AICD, reducing anti-tumor immunity. Mutant KRAS-activated circATXN7 fosters tumor immunoescape by sensitizing tumor-specific T cells to AICD. Hypoxia in tumors also promotes AICD via HIF1α-regulated glycolysis. Targeting these pathways may improve T cell persistence in immunotherapy.
Type 2 diabetes and chronic inflammation
In type 2 diabetic patients, OX40 amplifies AICD of mucosal-associated invariant T cells, potentially contributing to immune dysfunction. This links metabolic disease to altered regulation of T cell death.
From regulation of activation-induced cell death of T cells-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a candidate gene required for AICD? | CRISPR knockout in primary T cells or Jurkat cells |
| Does a specific point mutation alter AICD sensitivity? | CRISPR point mutation knock-in |
| Does a gene fusion or tag affect AICD regulation? | CRISPR knock-in of tag or reporter |
| Does overexpression of a gene protect from AICD? | Lentiviral overexpression in T cells |
| Which genes regulate AICD in a genome-wide manner? | CRISPR library screening |
| How does a gene affect AICD in vivo? | Adoptive transfer of edited T cells into mouse models |
How to Study the regulation of activation-induced cell death of T cells Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Flow cytometry (Annexin V/PI) | Apoptosis rate | Quantify AICD in T cell cultures |
| RNA-seq | Transcriptome changes | Identify AICD regulators |
| Western blot | Protein expression and cleavage | Confirm caspase activation |
| CRISPR knockout screen | Gene requirement for AICD | Discover novel regulators |
| CRISPR activation screen | Gene sufficiency to modulate AICD | Identify protective factors |
| Co-culture assays | T cell death induced by tumor cells | Model tumor immunoescape |
| Hypoxia chamber assays | AICD under low oxygen | Study HIF1α-dependent regulation |
| OX40 stimulation assays | Costimulation effects on AICD | Model type 2 diabetes AICD |
Flow cytometry and apoptosis assays
Flow cytometry with Annexin V and propidium iodide staining is standard to quantify AICD in T cells after TCR stimulation. This method measures the rate of apoptosis and can be combined with surface markers to identify T cell subsets.
Transcriptomics and RNA-seq
RNA sequencing can identify genes and pathways differentially expressed during AICD, including FasL and survival factors. This approach helps define the regulatory network controlling AICD.
Proteomics and immunoblotting
Western blotting and proteomics can measure caspase cleavage, FasL expression, and signaling intermediates during AICD. These methods confirm activation of death receptor pathways.
CRISPR screening and functional genomics
Genome-wide CRISPR knockout or activation screens can identify positive and negative regulators of AICD. Such screens are powerful for discovering novel regulators of GO:0070235.
How CRISPR Can Be Used to Study GO:0070235 regulation of activation-induced cell death of T cells
Knockout
CRISPR knockout of candidate genes in primary T cells or T cell lines can determine whether a gene is required for regulation of AICD. For example, knocking out FASLG or FAS abolishes Fas-mediated AICD. Knockout screens can systematically identify regulators.
Point Mutation
CRISPR point mutation knock-in can model disease-associated variants or phospho-mutants to test their effect on AICD. This allows precise dissection of signaling residues in FasL or death receptor pathways.
Knock-in
Knock-in of reporters, tags, or human disease alleles can visualize and quantify AICD regulators in live cells. Tagged knock-in of FasL or Fas enables tracking of protein localization and interactions.
Overexpression
Overexpression of candidate genes via lentiviral vectors can test sufficiency to protect from or promote AICD. For example, overexpression of anti-apoptotic BCL2 family members can reduce AICD.
How EDITGENE Supports regulation of activation-induced cell death of T cells Research
Researchers studying regulation of activation-induced cell death of T cells-related genes often need to determine whether a candidate gene is causally involved in AICD or merely correlated with it. EDITGENE provides CRISPR-based cell model services to enable such causal experiments in T cells and other relevant cell types.
Contact EDITGENE today to design your custom CRISPR model for regulation of activation-induced cell death of T cells research.
Frequently Asked Questions About regulation of activation-induced cell death of T cells
What is regulation of activation-induced cell death of T cells?
It is the biological process that modulates the occurrence or rate of activation-induced cell death (AICD) in T cells, defined as GO:0070235.
What genes are involved in regulation of activation-induced cell death of T cells?
Key genes include FASLG, FAS, TNFRSF4 (OX40), HIF1A, CASP3, CASP8, BCL2, NFKB1, and NFATC1, among others.
How does Fas/FasL signaling regulate AICD?
FasL induction and Fas engagement trigger caspase activation and apoptosis in activated T cells, and regulation of FasL expression is a key control point.
Why is AICD important for immune tolerance?
AICD eliminates activated autoreactive T cells and terminates immune responses, helping prevent autoimmunity.
How does hypoxia affect AICD?
HIF1α-regulated glycolysis promotes AICD and IFN-γ induction in hypoxic T cells.
Can tumors evade immunity by inducing AICD in T cells?
Yes, mutant KRAS-activated circATXN7 sensitizes tumor-specific T cells to AICD, contributing to tumor immunoescape.
What is the role of OX40 in AICD?
OX40 amplifies AICD of mucosal-associated invariant T cells in type 2 diabetic patients.
How can I study regulation of AICD using CRISPR?
CRISPR knockout, point mutation, knock-in, and overexpression models allow causal testing of candidate genes in AICD.
What methods measure AICD?
Flow cytometry with Annexin V/PI, RNA-seq, Western blot, and CRISPR screens are commonly used.
What diseases are linked to dysregulated AICD?
Autoimmunity, cancer immunoescape, and type 2 diabetes have been linked to altered AICD regulation.
Conclusion
GO:0070235 regulation of activation-induced cell death of T cells is a central process in immune homeostasis and disease. Its mechanisms involve TCR signaling, Fas/FasL, metabolic cues, and microenvironmental factors. Dysregulation contributes to autoimmunity, cancer immunoescape, and metabolic disease. CRISPR-based models and functional genomics provide powerful tools to dissect this process and identify therapeutic targets.
References
- 1. Janssen O et al.. 2000. Regulation of activation-induced cell death of mature T-lymphocyte populations.. Cell Tissue Res 301(1):85-99 PMID: 10928283
- 2. Arakaki R et al.. 2014. Mechanism of activation-induced cell death of T cells and regulation of FasL expression.. Crit Rev Immunol 34(4):301-14 PMID: 24941158
- 3. Russell JH. 1995. Activation-induced death of mature T cells in the regulation of immune responses.. Curr Opin Immunol 7(3):382-8 PMID: 7546404
- 4. Shen H et al.. 2024. HIF1α-regulated glycolysis promotes activation-induced cell death and IFN-γ induction in hypoxic T cells.. Nat Commun 15(1):9394 PMID: 39477954
- 5. Zhou C et al.. 2024. Mutant KRAS-activated circATXN7 fosters tumor immunoescape by sensitizing tumor-specific T cells to activation-induced cell death.. Nat Commun 15(1):499 PMID: 38216551
- 6. Budd RC. 2001. Activation-induced cell death.. Curr Opin Immunol 13(3):356-62 PMID: 11406369
- 7. Zhang M et al.. 2019. Activation-Induced Cell Death of Mucosal-Associated Invariant T Cells Is Amplified by OX40 in Type 2 Diabetic Patients.. J Immunol 203(10):2614-2620 PMID: 31578271
- 8. Zhang J et al.. 2004. Activation-induced cell death in T cells and autoimmunity.. Cell Mol Immunol 1(3):186-92 PMID: 16219166
